Home > Insider Trading > Filing (0001209191-14-003513)

Filing Details

Accession Number:: 0001209191-14-003513
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-01-16 16:50:31
Reporting Period:: 2014-01-15

Filing Date:: 2014-01-16
Accepted Time:: 2014-01-16 16:50:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1237831	Globus Medical Inc	GMED	Surgical & Medical Instruments & Apparatus (3841)	043744954

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1555392	M David Demski	Valley Forge Business Center 2560 General Armistead Avenue Audubon PA 19403	President And Coo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2014-01-15	96,813	$20.51	381,365	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$4.88	2019-08-06	18,461	18,461	Direct
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$11.87	2020-06-16	18,461	18,461	Direct
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$10.66	2021-10-27	18,461	18,461	Direct
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$15.34	2022-08-29	15,000	15,000	Direct
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$13.04	2023-01-24	40,000	40,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2019-08-06	18,461	18,461	Direct
2020-06-16	18,461	18,461	Direct
2021-10-27	18,461	18,461	Direct
2022-08-29	15,000	15,000	Direct
2023-01-24	40,000	40,000	Direct

Footnotes

This sale was pursuant to a Rule 10b5-1 Sales Plan dated September 9, 2013 and effective on October 9, 2013, which is intended to comply with Rule 10b5-1.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.25 to $20.75, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on June 16, 2010, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2011, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on October 27, 2011, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on August 29, 2012, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 24, 2013, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.